Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease

Virus Research

Volumn 178, Issue 2, 2013, Pages 430-436

  Shen, Huifang ^a   Xue, Chunyi ^a   Lv, Lishan ^a   Wang, Wei ^a   Liu, Qiliang ^a   Liu, Kang ^a   Chen, Xianxian ^a   Zheng, Jing ^a   Li, Xiaoming ^a   Cao, Yongchang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Avian influenza virus; Chimeric virus like particles; Immune response; Newcastle disease virus

Indexed keywords

AVIAN INFLUENZA VACCINE; CHIMERIC PROTEIN; HN PROTEIN; INACTIVATED VIRUS VACCINE; PHOSPHATE BUFFERED SALINE; VIRUS ANTIBODY; VIRUS LIKE PARTICLE VACCINE; VIRUS SIALIDASE;

ANTIBODY RESPONSE; ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHICKEN; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; IMMUNIZATION; NEWCASTLE DISEASE; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SF9 CELL; SINGLE DRUG DOSE; VIRUS ASSEMBLY; VIRUS LIKE AGENT;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; NEWCASTLE DISEASE VIRUS;

AVIAN INFLUENZA VIRUS; CHIMERIC VIRUS-LIKE PARTICLES; IMMUNE RESPONSE; NEWCASTLE DISEASE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; SURVIVAL ANALYSIS; VACCINES, SYNTHETIC; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES;

EID: 84888206375     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.09.009     Document Type: Article

References (39)

1. Alexander D.J. Newcastle disease and other avian paramyxoviruses. Rev. Sci. Tech. 2000, 19(2):443-462.
2. Alexander D.J. A review of avian influenza in different bird species. Vet. Microbiol. 2000, 74(1-2):3-13.
3. Barman S., Adhikary L., Chakrabarti A.K., Bernas C., Kawaoka Y., Nayak D.P. Role of transmembrane domain and cytoplasmic tail amino acid sequences of Influenza A virus neuraminidase in raft association and virus budding. J. Virol. 2004, 78(10):5258-5269.
4. Berinstein A., Vazquez-Rovere C., Asurmendi S., Gómez E., Zanetti F., Zabal O., Tozzini A., Conte Grand D., Taboga O., Calamante G., Barrios H., Hopp E., Carrillo E. Mucosal and systemic immunization by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine 2005, 23(48-49):5583-5589.
5. Boursnell M.E., Green P.F., Samson A.C., Campbell J.I., Deuter A., Peters R.W., Millar N.S., Emmerson P.T., Binns M.M. A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology 1990, 178(1):297-300.
6. Bright R.A., Carter D.M., Crevar C.J., Toapanta F.R., Steckbeck J.D., Cole K.S., Kumar N.M., Pushko P., Smith G., Tumpey T.M., Ross T.M. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One 2008, 3(1):e1501.
7. Bright R.A., Carter D.M., Daniluk S., Toapanta F.R., Ahmad A., Gavrilov V., Massare M., Pushko P., Mytle N., Rowe T., Smith G., Ross T.M. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007, 25(19):3871-3878.
8. Chen J.R., Ma C., Wong C.H. Vaccine design of hemagglutinin glycoprotein against influenza. Trends Biotechnol. 2011, 29(9):426-434.
9. Crawford J., Wilkinson B., Vosnesensky A., Smith G., Garcia M., Stone H., ML., P. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 1999, 17(18):2265-2274.
10. Edbauer C., Weinberg R., Taylor J., Rey-Senelonge A., Bouquet J.F., Desmettre P., Paoletti E. Protection of chickens with a recombinant fowlpox virus expressing the Newcastle disease virus hemagglutinin-neuraminidase gene. Virology 1990, 179(2):901-904.
11. Enami M., Enami K. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 1996, 70(10):6653-6657.
12. Ge J.Y., Deng G.H., Wen Z.Y., Tian G.B., Wang Y., Shi J.Z., Wang X.J., Li Y.B., Hu S., Jiang Y., Yang C., Yu K., Bu Z., Chen H. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 2007, 81(1):150-158.
13. Gillim-Ross L., Subbarao K. Emerging respiratory viruses: challenges and vaccine strategies. Clin. Microbiol. Rev. 2006, 19(4):614-636.
14. Grgacic E.V.L., Anderson D.A. Virus-like particles: passport to immune recognition. Methods 2006, 40(1):60-65.
15. Horimoto T., Kavaoka Y. Pandemic threat posed by avian influenza A viruses. Clin. Microbiol. Rev. 2001, 14(1):129-149.
16. Song J.M., Hossain J., Yoo D.G., Lipatov A.S., Davis C.T., Quan F.S., Chen L.M., Hogan R.J., Donis R.O., Compans R.W., Kang S.M. Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles. Virology 2010, 405(1):165-175.
17. Jennings G.T., Bachmann M. The coming of age of virus-like particle vaccines. Biol. Chem. 2008, 389(5):521-536.
18. Jin H., Leser G.P., Zhang J., Lamb R.A. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 1997, 16(6):1236-1247.
19. King D.J. Avian paramyxovirus type 1 from pigeons: isolate characterization and pathogenicity after chicken or embryo passage of selected isolates. Avian Dis. 1996, 40(3):707-714.
20. Maeda Y., Hatta M., Takada A., Watanabe T., Goto H., Neumann G., Kawaoka Y. Live bivalent vaccine for parainfluenza and influenza virus infections. J. Virol. 2005, 79(11):6674-6679.
21. Melanson V.R., Iorio R.M. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J. Virol. 2006, 80(2):623-633.
22. Mirza A.M., Sheehan J.P., Hardy L.W., Glickman R.L., Iorio R.M. Structure and function of a membrane anchor-less form of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. J. Biol. Chem. 1993, 268(28):21425-21431.
23. Mozdzanowska K., Maiese K., Furchner M., Gerhard W. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection. Virology 1999, 254(1):138-146.
24. Kamiya N., Niikura M., Ono M., Kai C., Matsuura Y., Mikami T. Protective effect of individual glycoproteins of Newcastle disease virus expressed in insect cells: the fusion protein derived from an avirulent strain had lower protective efficacy. Virus Res. 1994, 32(3):373-379.
25. Noad R., Roy P. Virus-like particles as immunogens. Trends Microbiol. 2003, 11(9):438-444.
26. Normile D. Avian influenza. China will attempt largest-ever animal vaccination campaign. Science 2005, 310(5752):1256-1257.
27. Park M.S., Steel J., García-Sastre A., Swayne D., Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. PNAS 2006, 103(21):8203-8208.
28. Pushko P., Tumpey T.M., Bu F., Knell J., Robinson R., Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005, 23(50):5751-5759.
29. Qiao C.L., Yu K.Z., Jiang Y.P., Jia Y.Q., Tian G.B., Liu M., Deng G.-H., Wang X.-R., Meng Q.-W., Tang X.-Y. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 2003, 32:25-31.
30. Quan F.S., Huang C.Z., Compans R.W., Kang S.M. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J. Virol. 2007, 81(7):3514-3524.
31. Quan F.S., Steinhauer D., Huang C.Z., Ross T.M., Compans R.W., Kang S.M. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine 2008, 26(26):3352-3361.
32. Roldão A., Mellado M.C.M., Castilho L.R., Carrondo M.J.T., Alves P.M. Virus-like particles in vaccine development. Vaccine 2010, 9(10):1149-1176.
33. Ross T.M., Mahmood K., Crevar C.J., Schneider-Ohrum K., Heaton P.M., Bright R.A. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS One 2009, 4(6):e6032.
34. Russell R., Paterson R.G., Lamb R.A. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology 1994, 199(1):160-168.
35. Tang X.C., Lu H.R., Ross T.M. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine 2010, 28:6821-6831.
36. Wang W., Chen X., Xue C., Du Y., Lv L., Liu Q., Li X., Ma Y., Shen H., Cao Y. Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein. Vaccine 2012, 10.1016/j.vaccine.2012.09.048.
37. Webby R.J., Perez D.R., Coleman J.S., Guan Y., Knight J.H., Govorkova E.A., McClain-Moss L.R., Peiris J.S., Rehg J.E., Tuomanen E.I., Webster R.G. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 2004, 363:1099-1103.
38. Wu C.Y., Yeh Y.C., Yang Y.C., Chou C., Liu M.T., Wu H.S., Chan J.T., Hsiao P.W. Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS One 2010, 5(3):e9784.
39. Yang D.G., Chung Y.C., Lai Y.K., Lai C.W., Liu H.J., Hu Y.C. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol. Ther. 2007, 15:989-996.